Development of neurological disease remedy using mushroom (Psilocybe argentipes)
| Project/Area Number |
20580180
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Wood science
|
|---|
| Research Institution | Takasaki University of Health and Welfare |
|---|
Principal Investigator |
EGUCHI Fumio Takasaki University of Health and Welfare, 健康福祉学部, 教授 (60337467)
|
|---|
| Project Period (FY) |
2008 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2010: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Keywords | きのこ / シロシビン / シロシン / ヒカゲシビレタケ / マジック・マッシュルーム / 抗うつ薬 / 担子菌類 / 神経系疾患 / 担子菌 / 中枢神経 / 催幻覚性 / 脅迫神経症 / 神経疾患 |
|---|
| Research Abstract |
I clarified the physiology characteristic about the mycelium of the Psilocybe argentipes. Psilocybe argentipes as the therapeutic drug of the obsessive-compulsive disorder is possible. One of the mechanism was action to the monoamine in the brain. This study was a result to help treatment of the obsessive-compulsive disorder.
|
Report
(4 results)
Research Products
(24 results)
